摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-isopropylphenyl)propanoic acid | 365555-13-1

中文名称
——
中文别名
——
英文名称
3-(2-isopropylphenyl)propanoic acid
英文别名
Benzenepropanoic acid, 2-(1-methylethyl)-;3-(2-propan-2-ylphenyl)propanoic acid
3-(2-isopropylphenyl)propanoic acid化学式
CAS
365555-13-1
化学式
C12H16O2
mdl
——
分子量
192.258
InChiKey
VAKITVVRJHONDZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(2-isopropylphenyl)propanoic acid 在 rhodium(II) acetate dimer 、 氯化亚砜 作用下, 以 乙醚二氯甲烷甲苯 为溶剂, 生成 5-isopropyl-β-tetralone
    参考文献:
    名称:
    Structure–Activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH2 at the human melanocortin-1 and -4 receptors: histidine substitution
    摘要:
    Systematic substitution of His(6) residue using non-selective hMC4R pentapeptide agonist (Bu-His(6)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)- NH2) as the template led to the identification of Bu-Atc(6)(2-aminotetraline-2-carboxylic acid)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)-NH2 which showed moderate selectivity towards hMC4R over hMC1R. Further SAR studies resulted in the discovery of Penta-5-BrAtc(6)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)-NH2 and Penta-5-Me(2)NMAtc(6)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)-NH2 which are potent hMC4R agonists and are inactive in hMC1R, hMC3R and hMC5R agonist assays. (C) 2002 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(02)00830-2
  • 作为产物:
    描述:
    2-碘异丙基苯甲醇 、 palladium diacetate 、 氢氧化钾magnesium三乙胺三(邻甲基苯基)磷 作用下, 以 乙醇 为溶剂, 生成 3-(2-isopropylphenyl)propanoic acid
    参考文献:
    名称:
    Structure–Activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH2 at the human melanocortin-1 and -4 receptors: histidine substitution
    摘要:
    Systematic substitution of His(6) residue using non-selective hMC4R pentapeptide agonist (Bu-His(6)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)- NH2) as the template led to the identification of Bu-Atc(6)(2-aminotetraline-2-carboxylic acid)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)-NH2 which showed moderate selectivity towards hMC4R over hMC1R. Further SAR studies resulted in the discovery of Penta-5-BrAtc(6)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)-NH2 and Penta-5-Me(2)NMAtc(6)-DPhe(7)-Arg(8)-Trp(9)-Gly(10)-NH2 which are potent hMC4R agonists and are inactive in hMC1R, hMC3R and hMC5R agonist assays. (C) 2002 Published by Elsevier Science Ltd.
    DOI:
    10.1016/s0960-894x(02)00830-2
点击查看最新优质反应信息

文献信息

  • Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
    申请人:Goble D. Stephen
    公开号:US20070238723A1
    公开(公告)日:2007-10-11
    Cyclopentyl compounds linked to a benzoxazinyl group through an amido moiety utilizing the ring nitrogen of the benzoxazine, and further substituted with a heterocyclic moiety, such compounds represented by formula I: which are used to modulate the CCR-2 chemokine receptor to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis; and pharmaceutical compositions comprising these compounds and the use of these compounds and compositions.
    环戊基化合物通过酰胺基团与苯并噁唑基团相连,利用苯并噁唑环的环氮原子,并进一步用杂环基团取代,这些化合物由式I表示: 用于调节CCR-2趋化因子受体,以预防或治疗炎症和免疫调节性疾病和疾病,过敏性疾病,包括过敏性鼻炎,皮炎,结膜炎和哮喘,以及类风湿性关节炎和动脉粥样硬化等自身免疫病理病变;以及包含这些化合物的药物组合物和这些化合物和组合物的使用。
  • Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
    申请人:——
    公开号:US20010056179A1
    公开(公告)日:2001-12-27
    Peptides of formulae I, II and III selectively activate melanocortin-4 (MC-4) receptor activity. 1
    公式I、II和III的肽选择性地激活黑色素皮质素-4(MC-4)受体活性。
  • Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activity
    申请人:——
    公开号:US20020143141A1
    公开(公告)日:2002-10-03
    Peptides cyclized via disulfide or lactam bridges having melanocortin-4 receptor (MC4-R) agonist activity useful for treatment of obesity.
    经过二硫键或内酰胺桥环化的肽具有黑色素皮质激素受体(MC4-R)激动剂活性,适用于治疗肥胖症。
  • Selective linear peptides with melanocor tin-4 receptor (MC4-R) agonist activity
    申请人:——
    公开号:US20030229200A1
    公开(公告)日:2003-12-11
    Peptides of formulae I, II and III that selectively activate melanocortin-4 (MC-4) receptor activity. 1
    化学式为I、II和III的多肽,可选择性激活黑色素细胞激素-4(MC-4)受体活性。
  • Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity
    申请人:Chen Li
    公开号:US20080177036A1
    公开(公告)日:2008-07-24
    Peptides of formulae I, II and III that selectively activate melanocortin-4 (MC-4) receptor activity.
    化学式为I、II和III的肽,可选择性地激活黑色素细胞激素受体-4(MC-4)的活性。
查看更多